drugset / Trial / NCT00343954
PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate PK and PD responses to L-citrulline given orally for four weeks to patients with sickle cell disease who are otherwise healthy.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-citrulline | Other / unclassified | 1000 mg | Oral |